Maytox® should not be used by individuals with hypersensitivity to its ingredients, active infections at the injection site, or those with conditions like myasthenia gravis or Lambert-Eaton syndrome. It is also contraindicated during pregnancy or lactation.

The effects of Maytox® usually last between 16 to 26 weeks. The duration can vary depending on the condition treated and individual patient response.

Yes, common side effects include muscle weakness, pain at the injection site, headache, dry mouth, and in some cases, temporary difficulty swallowing. Consult your doctor if side effects persist or worsen.

Maytox® is administered as an intramuscular injection. The dosage and specific muscles targeted depend on the condition being treated. Only a trained healthcare professional should perform the injection.

Maytox® is approved for treating spasticity in children aged 2-17 years with cerebral palsy. However, its use in children under 7 years for certain conditions is not established. Always consult a specialist for pediatric use.

Maytox® is not approved for the prophylaxis of episodic migraines (14 or fewer headache days per month). It is recommended to consult a healthcare professional for other migraine treatments.

Maytox® must be stored between 2°C and 8°C (36°F to 46°F) and used within 24 hours of reconstitution. Do not freeze it after reconstitution.